Corcept Therapeutics
-
Ticker
CORT
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Menlo Park, California
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders. It focuses on disorders that are associated with a steroid hormone called cortisol.
REPORT RATINGS
4.8 / 5.0 (306)
Corcept Therapeutics reports have an aggregate usefulness score of 4.8 based on 306 reviews.
Corcept Therapeutics
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports